Throughout his career, Dr. Yeung has published more than 300 papers in top-tier journals, covering a wide range of interventional cardiology topics. From percutaneous coronary artery intervention to transcatheter aortic valve replacement, Dr. Yeung has been on the leading edge of interventional cardiology breakthroughs as a researcher and scientist.
Dr. Yeung’s early research was focused on the coronary physiology of endothelial dysfunction and intimal thickening, a result of his study under Peter Ganz, MD, of Harvard Medical School/Brigham and Women’s Hospital (now at University of California, San Francisco). His recent work with William Fearon, MD, has led to physiological studies in the coronary arteries using fractional flow reserve (FFR) and index of microcirculatory resistance (IMR). Most recently, this line of research led to the FAME 3 trial that compared the results of FFR-guided percutaneous coronary intervention (PCI) to coronary artery bypass graft (CABG).
As a prominent educator, Dr. Yeung is also playing an integral role in training the next generation of interventional cardiologists. He has served as chairman of the American Board of Internal Medicine Interventional Board Committee as well as writing textbooks for fellows in training and practicing interventionalists.
“I look forward to the years ahead as we continue to forge paths through more research and discoveries in interventional cardiology,” said Dr. Yeung. “I’m honored to work alongside so many talented physicians and researchers who share a passion for healing through science.”